| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $186.3M | +12.5% |
| SG&A Expense | $73.3M | +24.7% |
| Operating Income | -$259.7M | -15.7% |
| Interest Expense | $1.9M | +0.7% |
| Income Tax | $0 | — |
| Net Income | -$245.6M | -10.7% |
| EPS (Basic) | -$2.92 | +10.4% |
| EPS (Diluted) | -$2.92 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.9M | -60.2% |
| Short-term Investments | $317.3M | +47.0% |
| Current Assets | $378.2M | +3.9% |
| Total Assets | $566.3M | +2.6% |
| Current Liabilities | $48.5M | +23.8% |
| Total Liabilities | $73.8M | +18.7% |
| Stockholders' Equity | $492.6M | +0.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$194.9M | -9.4% |
| Capital Expenditures | $16.4M | +96.6% |
| Investing Cash Flow | -$98.1M | -41.5% |
| Financing Cash Flow | $208.4M | +34.2% |
| Free Cash Flow | -$211.4M | -13.3% |
| +10.4% |